317 related articles for article (PubMed ID: 24879983)
1. Drug-induced liver injury with autoimmune features.
deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
[TBL] [Abstract][Full Text] [Related]
2. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced autoimmune-like hepatitis.
Czaja AJ
Dig Dis Sci; 2011 Apr; 56(4):958-76. PubMed ID: 21327704
[TBL] [Abstract][Full Text] [Related]
4. Seven cases of autoimmune hepatitis that developed after drug-induced liver injury.
Sugimoto K; Ito T; Yamamoto N; Shiraki K
Hepatology; 2011 Nov; 54(5):1892-3. PubMed ID: 21725992
[No Abstract] [Full Text] [Related]
5. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
6. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
7. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Björnsson ES; Medina-Caliz I; Andrade RJ; Lucena MI
Hepatol Commun; 2022 Aug; 6(8):1895-1909. PubMed ID: 35596597
[TBL] [Abstract][Full Text] [Related]
8. A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.
Morii K; Nishisaka M; Nakamura S; Oda T; Aoyama Y; Yamamoto T; Kishida H; Okushin H; Uesaka K
J Clin Pharm Ther; 2014 Oct; 39(5):573-6. PubMed ID: 24989642
[TBL] [Abstract][Full Text] [Related]
9. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
[TBL] [Abstract][Full Text] [Related]
10. Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Chalasani N; Li YJ; Dellinger A; Navarro V; Bonkovsky H; Fontana RJ; Gu J; Barnhart H; Phillips E; Lammert C; Schwantes-An TH; Nicoletti P; Kleiner DE; Hoofnagle JH;
J Hepatol; 2023 Feb; 78(2):293-300. PubMed ID: 36152763
[TBL] [Abstract][Full Text] [Related]
11. Hydralazine-Induced Autoimmune Hepatitis Precipitated by the Blood Transfusion.
Amjad W; John G; Gulru S
Am J Ther; 2018; 25(4):e514-e516. PubMed ID: 29045246
[No Abstract] [Full Text] [Related]
12. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
Björnsson E; Talwalkar J; Treeprasertsuk S; Kamath PS; Takahashi N; Sanderson S; Neuhauser M; Lindor K
Hepatology; 2010 Jun; 51(6):2040-8. PubMed ID: 20512992
[TBL] [Abstract][Full Text] [Related]
13. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
14. Drug induced liver injury and its relationship to autoimmune hepatitis.
Weiler-Normann C; Schramm C
J Hepatol; 2011 Oct; 55(4):747-9. PubMed ID: 21396413
[No Abstract] [Full Text] [Related]
15. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
16. Drug-induced hepatitis with autoimmune features during minocycline therapy.
Abe M; Furukawa S; Takayama S; Michitaka K; Minami H; Yamamoto K; Horiike N; Onji M
Intern Med; 2003 Jan; 42(1):48-52. PubMed ID: 12583618
[TBL] [Abstract][Full Text] [Related]
17. Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication.
Hydes T; Wright M; Jaynes E; Nash K
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24599428
[TBL] [Abstract][Full Text] [Related]
18. Acute Liver Injury in a Patient Treated With Rosuvastatin: A Rare Adverse Effect.
Shah J; Lingiah V; Pyrsopoulos N; Galan M
Gastroenterology Res; 2019 Oct; 12(5):263-266. PubMed ID: 31636777
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced autoimmune hepatitis: A minireview.
Tan CK; Ho D; Wang LM; Kumar R
World J Gastroenterol; 2022 Jun; 28(24):2654-2666. PubMed ID: 35979160
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
